Yatırımcı.AI

USUSDSep 28, 23:23

Intellia Therapeutics Inc

Intellia Therapeutics Inc NTLA

USD 11.42−0.33 (−2.81%)

About TRY 559.58 · converted at USD/TRY 49.0003, September 29, 2026, 14:34

Volume
3M
Day range
11.33 – 11.80
Previous close
11.75
Market cap
USD 1.6B

Key Data

USD 1.6B
USD −3.25
52 weeks
8.0427.98
Day range
11.3311.80
1-year return
−35.70%
Previous close
11.75
Open
11.72
Avg. volume (200d)
5M
Sector
Healthcare
Industry
Biotechnology

Technical Signals

Technical signals

Only our Plus members can access this area.

AI Models

AI models

Only our Plus members can access this area.

About Intellia Therapeutics Inc

Intellia Therapeutics Inc (NTLA) last traded at 11.42 USD on the US stock market, a daily move of −2.81%. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 14:34, this price equals about TRY 559.58; the conversion is for information only and the rate a broker applies may differ. Market capitalization is 1.6B USD, earnings per share −3.25 USD, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Biotechnology industry. The 52-week range is 8.04 – 27.98 USD; the one-year return is −35.70%.

Frequently Asked Questions

Intellia Therapeutics Inc (NTLA) last traded at 11.42 USD, a daily change of −2.81%. Prices are delayed by at least 15 minutes.

The last price of Intellia Therapeutics Inc (NTLA) is USD 11.42. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 14:34, that is about TRY 559.58. The conversion is for information only; trades use the exchange rate and fees your broker applies.

US stocks such as Intellia Therapeutics Inc (NTLA) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.

NTLA trades at a price-to-earnings ratio of —, with earnings per share of −3.25 USD and a market capitalization of 1.6B USD. Ratios use the latest reported results and the current price.

Over the past 52 weeks NTLA traded between 8.04 and 27.98 USD; the one-year return is −35.70%.

The current dividend yield of NTLA is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.

Intellia Therapeutics Inc (NTLA) is listed on the US stock market; its sector is Healthcare and its industry is Biotechnology.

Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.